We are live on
!
Find out more
PAWC
P.A.W. Capital Portfolio holdings
AUM
$36.7M
1-Year Est. Return
6.81%
This Fund
S&P 500
This Quarter
Est. Return
-0.69%
1 Year Est. Return
-6.81%
3 Year Est. Return
-2.78%
5 Year Est. Return
-4.97%
10 Year Est. Return
+711.77%
AUM
$89.1M
AUM Growth
+$757K
(+0.86%)
Cap. Flow
+$1.04M
Cap. Flow
% of AUM
1.16%
Top 10 Holdings %
Top 10 Hldgs %
40.31%
Holding
70
New
6
Increased
13
Reduced
22
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SNCR
Synchronoss Technologies
SNCR
|
+$3.91M |
| 2 |
Morgan Stanley
MS
|
+$1.15M |
| 3 |
Marchex
MCHX
|
+$741K |
| 4 |
VRTU
Virtusa Corporation
VRTU
|
+$663K |
| 5 |
Weyerhaeuser
WY
|
+$641K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Iovance Biotherapeutics
IOVA
|
+$1.54M |
| 2 |
Qualcomm
QCOM
|
+$975K |
| 3 |
Cognizant
CTSH
|
+$872K |
| 4 |
Calix
CALX
|
+$848K |
| 5 |
PCL
PLUM CREEK TIMBER CO (REIT)
PCL
|
+$716K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.78% |
| 2 | Financials | 15.02% |
| 3 | Healthcare | 13.89% |
| 4 | Communication Services | 10.24% |
| 5 | Energy | 4.86% |
Similar funds
ICP
RH
CI
GC
FC
CM
BAM
AP
P.A.W. Capital's Q1 2016 Portfolio in Review
As of Q1 2016, P.A.W. Capital held 70 positions worth $89.1M, up 0.86% from $88.4M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
P.A.W. Capital's Q1 2016 filing shows 6 new, 13 increased, 22 reduced and 5 closed positions. Its largest new stake was Morgan Stanley: 45,000 shares worth $1.13M. The largest sale was Iovance Biotherapeutics, an estimated $1.54M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 33% a quarter earlier, followed by Financials and Healthcare.
- P.A.W. Capital's largest Q1 2016 buy was Morgan Stanley: 45,000 shares worth $1.13M.
- P.A.W. Capital added most to Synchronoss Technologies in Q1 2016, an estimated $3.91M increase.
- P.A.W. Capital's biggest Q1 2016 reduction was Qualcomm, cutting an estimated $975K.
- P.A.W. Capital fully exited Iovance Biotherapeutics in Q1 2016, selling an estimated $1.54M.
- P.A.W. Capital's ten largest holdings make up 40% of its $89.1M portfolio in Q1 2016.
- P.A.W. Capital opened 6 new positions and closed 5 in Q1 2016.
- P.A.W. Capital's portfolio value rose 0.86% quarter-over-quarter to $89.1M.
Based on P.A.W. Capital's 13F filing for Q1 2016, filed 5 May 2016.